Protalix BioTherapeutics, Inc.

NYSEAM:PLX Stock Report

Market Cap: US$124.4m

Protalix BioTherapeutics, Inc. Company Information

Protalix BioTherapeutics, Inc.'s employee growth, exchange listings and data sources

Key Information

  • Name: Protalix BioTherapeutics, Inc.
  • Ticker: PLX
  • Exchange: NYSEAM
  • Founded: 1993
  • Industry: Biotechnology
  • Sector: Pharmaceuticals & Biotech
  • Market Cap: US$124.441m
  • Shares Outstanding: 73.63m
  • Website: https://www.protalix.com

Number of Employees

Location

  • Protalix BioTherapeutics, Inc.
  • Science Park
  • 2 Snunit St.
  • Karmiel
  • 2161401
  • Israel

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
PLXNYSEAM (NYSE MKT LLC)YesOrdinary SharesUSUSDJan 2007
PBDADB (Deutsche Boerse AG)YesOrdinary SharesDEEURJan 2007

Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2024/11/25 09:32
End of Day Share Price 2024/11/22 00:00
Earnings2024/09/30
Annual Earnings2023/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.